Dennis H. Oh, MD, PhD

---

Education

Stanford University, Stanford, CA, B.S. June 1985, Chemistry (w/ Honors), Biological Sciences
Stanford University, Stanford, CA, Ph.D., June 1991, Biophysics
Stanford University, Stanford, CA, M.D., June 1993, Medicine

---

Professional Experience

• 1985-1993
  Trainee, Medical Scientist Training Program (MSTP), Stanford University School of Medicine
• 1987-1991
  Graduate student, Biophysics Program, Stanford University
• 1993-1994
  Internship, Department of Medicine, Brigham and Women's Hospital Clinical Fellow in Medicine, Harvard Medical School
• 1994-1998
  Residency, Department of Dermatology, Stanford University School of Medicine
• 1996-2000
  Postdoctoral fellow, Department of Dermatology and Biological Sciences, Stanford University
• 1998-2000
  Clinical Instructor, Department of Dermatology, Stanford University School of Medicine
• 7/00-10/00
  Assistant Adjunct Professor, Department of Dermatology, University of California, San Francisco
• 7/00-present
  Assistant Chief of Dermatology, San Francisco VA Medical Center
• 10/00-present
  Assistant Professor in Residence, Department of Dermatology, University of California, San Francisco
• 1/1/01-7/1/01
  Acting Chief of Dermatology, San Francisco VA Medical Center

---

Honors & Awards

• 1983
  American Heart Association Summer Student Research Internship, Lawrence Berkeley Laboratory, University of California at Berkeley
• 1983, 1984
  Korean Honor Scholarship, Republic of Korea
• 1985
  Graduation with Honors (Chemistry) and with Distinction, Stanford University
• 1985
  Firestone Medal for Excellence in Research, Stanford University
• 1985
  Phi Beta Kappa, Stanford University
• 1985
  Phi Lambda Upsilon (Chemistry), Stanford University
• 1985-1992
  National Research Service Award (Medical Scientist Training Program, Stanford University Medical School)
• 1996-1997
  Bank of America-Giannini Foundation Medical Research Fellow
• 1996-1997
  Cancer Research Foundation of America Fellowship
• 1997-2002
  Mentored Clinical Scientist Development Award (K08)
• 2001-2002
  Dermatology Foundation Research Grant
• 2001-2002
  U.C. San Francisco REAC Award
• 2002-2005
  VA Merit Review Entry Program Award

---

Selected Publications

1. Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis: Part I. J Am Acad Dermatol. 2012 Nov; 67(5):803.e1-803.e12.
   View on PubMed
2. Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis: Part II. J Am Acad Dermatol. 2012 Nov; 67(5):817.e1-817.e11.
   View on PubMed
3. Hall BJ, Pincus LB, Yu SS, Oh DH, Wilson AR, McCalmont TH. Immunohistochemical prognostication of Merkel cell carcinoma: p63 expression but not polyomavirus status correlates with outcome. J Cutan Pathol. 2012 Oct; 39(10):911-7.
   View on PubMed
4. Demetriou SK, Ona-Vu K, Sullivan EM, Dong TK, Hsu SW, Oh DH. Defective DNA repair and cell cycle arrest in cells expressing Merkel cell polyomavirus T antigen. Int J Cancer. 2012 Oct 15; 131(8):1818-27.
   View on PubMed
5. Demetriou SK, Ona-Vu K, Teichert AE, Cleaver JE, Bikle DD, Oh DH. Vitamin D receptor mediates DNA repair and is UV inducible in intact epidermis but not in cultured keratinocytes. J Invest Dermatol. 2012 Aug; 132(8):2097-100.
   View on PubMed
6. Armstrong AW, Wu J, Kovarik CL, Goldyne ME, Oh DH, McKoy KC, Shippy AM, Pak HS. State of teledermatology programs in the United States. J Am Acad Dermatol. 2012 Nov; 67(5):939-44.
   View on PubMed
7. Huang ZM, Chinen M, Chang PJ, Xie T, Zhong L, Demetriou S, Patel MP, Scherzer R, Sviderskaya EV, Bennett DC, Millhauser GL, Oh DH, Cleaver JE, Wei ML. Targeting protein-trafficking pathways alters melanoma treatment sensitivity. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):553-8.
   View on PubMed
8. Revet I, Feeney L, Bruguera S, Wilson W, Dong TK, Oh DH, Dankort D, Cleaver JE. Functional relevance of the histone gammaH2Ax in the response to DNA damaging agents. Proc Natl Acad Sci U S A. 2011 May 24; 108(21):8663-7.
   View on PubMed
9. Krishnan R, Oh DH. Structural determinants of photoreactivity of triplex forming oligonucleotides conjugated to psoralens. J Nucleic Acids. 2010; 2010.
   View on PubMed
10. de Feraudy S, Ridd K, Richards LM, Kwok PY, Revet I, Oh D, Feeney L, Cleaver JE. The DNA damage-binding protein XPC is a frequent target for inactivation in squamous cell carcinomas. Am J Pathol. 2010 Aug; 177(2):555-62.
    View on PubMed
11. Oh DH, Spivak G. Hereditary photodermatoses. Adv Exp Med Biol. 2010; 685:95-105.
    View on PubMed
12. Pincus LB, McCalmont TH, Neuhaus IM, Kasper R, Oh DH. Basal cell carcinomas arising within multiple trichoepitheliomas. J Cutan Pathol. 2008 Oct; 35 Suppl 1:59-64.
    View on PubMed
13. Hsiao JL, Oh DH. The impact of store-and-forward teledermatology on skin cancer diagnosis and treatment. J Am Acad Dermatol. 2008 Aug; 59(2):260-7.
    View on PubMed
14. Oh DH, Suzara V, Krishnan R. Modulation of psoralen DNA crosslinking kinetics associated with a triplex-forming oligonucleotide. Photochem Photobiol. 2008 May-Jun; 84(3):727-33.
    View on PubMed
15. Krupinski E, Burdick A, Pak H, Bocachica J, Earles L, Edison K, Goldyne M, Hirota T, Kvedar J, McKoy K, Oh D, Siegel D, Antoniotti N, Camacho I, Carnahan L, Boynton P, Bakalar R, Evans R, Kinel A, Kuzmak P, Madden BC, Peters S, Rosenthal L, Simmons S, Bernard J, Linkous J. American Telemedicine Association's Practice Guidelines for Teledermatology. Telemed J E Health. 2008 Apr; 14(3):289-302.
    View on PubMed
16. Mogi S, Butcher CE, Oh DH. DNA polymerase eta reduces the gamma-H2AX response to psoralen interstrand crosslinks in human cells. Exp Cell Res. 2008 Feb 15; 314(4):887-95.
    View on PubMed
17. Ferguson-Yates BE, Li H, Dong TK, Hsiao JL, Oh DH. Impaired repair of cyclobutane pyrimidine dimers in human keratinocytes deficient in p53 and p63. Carcinogenesis. 2008 Jan; 29(1):70-5.
    View on PubMed
18. Mogi S, Oh DH. gamma-H2AX formation in response to interstrand crosslinks requires XPF in human cells. DNA Repair (Amst). 2006 Jun 10; 5(6):731-40.
    View on PubMed
19. Ferguson BE, Oh DH. Proficient global nucleotide excision repair in human keratinocytes but not in fibroblasts deficient in p53. Cancer Res. 2005 Oct 1; 65(19):8723-9.
    View on PubMed
20. Oh DH, Yeh K. Differentiating human keratinocytes are deficient in p53 but retain global nucleotide excision repair following ultraviolet radiation. DNA Repair (Amst). 2005 Sep 28; 4(10):1149-59.
    View on PubMed

View on UCSF Profiles